NWBO
NORTHWEST BIOTHERAPEUTICS INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
Signal stack
Where each data set points today.
- Short sellersSTEADY
Short interest −4.8% to 73.13M shares. 5.9 days to cover.
- TrendDOWNTREND
1% below its 50-day average. New closing low $0.1500 on Oct 23.
- SocialQUIET
Crowd 50° (neutral) this week from 2 mentions: 0 bullish, 0 bearish. No setup call.
The Street
last action Mar 2014Price is below the lowest target. Median implies +519%.Targets as of Oct 28, 2026.
| Date | Firm | Rating |
|---|---|---|
| Mar 12, 2014 | Oppenheimer DOWNGRADE | Perform |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | -$0.05 | -$0.05–-$0.05 | +0.0% | $0.00 |
| Next FY | -$0.07 | -$0.07–-$0.07 | +0.0% | $38.9M |
Short side
FINRA· Oct 15, 2026SecBot reports
2 filings · 0 bullish · 1 bearish · 1 neutral- BEARISH 424B5Jul 31, 2026
Northwest Biotherapeutics filed a 424B5 prospectus supplement to register 40,325,000 shares of…
The Yorkville convertible note is a classic 'death spiral' structure — variable conversion at a discount to market — which will create persistent downward selling pressure as the holder converts and…
- NEUTRAL EFFECTApr 21, 2026
Northwest Biotherapeutics Inc. has an effective shelf registration (Form S-3) that allows the…
Monitor for future 424B filings or 8-Ks that may announce specific takedowns from this shelf; the lack of immediate capital raise details makes this a routine procedural update with limited…
All NWBO filing & press-release reports (2)
- 424B5 reportJul 31, 2026
- EFFECT reportApr 21, 2026